All companies
Visit website
DataBiologics
OperatingDataBiologics, Inc.
Healthcare · Founded 2018
Harnesses real patient feedback to benchmark providers and products in cash-pay medicine
Valuation cap ⓘ
$10.0M
As of Apr 2025 · from DATABIOLOGICS Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$0
Across 1 round since 2024
Financials
FY2022–FY2023 · from SEC filings · hover any figure for its source$59K
−$334K
2022
$275K
−$485K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
Income statement
Revenue
$58,512
$275,446
Cost of goods sold
$14,852
$0
Gross margin
75%
100%
Net income
-$334,463
-$484,507
Taxes paid
$0
$0
Balance sheet
Cash
$9,596
$179,344
Accounts receivable
$0
$0
Total assets
$260,490
$403,367
Short-term debt
$0
$106
Long-term debt
$130,000
$717,278
Total liabilities
$130,000
$717,384
Other
Headcount
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$10.0M
Valuation cap
DATABIOLOGICS Future Equity SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised — / $1.2MValuation cap $10M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001913930
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.